Dietary fatty acid composition and metabolic syndrome in Tehranian adults

Nutrition

Volumn 27, Issue 10, 2011, Pages 1002-1007

  Hekmatdoost, Azita ^a,b   Mirmiran, Parvin ^a,b   Hosseini Esfahani, Firoozeh ^b   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dietary fatty acids; Metabolic syndrome

Indexed keywords

FAT; LINOLEIC ACID; OLEIC ACID; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CROSS-SECTIONAL STUDY; DIETARY FATTY ACID COMPOSITION; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; FOOD COMPOSITION; HUMAN; IRAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DIET; DIETARY FATS; FATTY ACIDS; FEMALE; HUMANS; IRAN; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; RISK FACTORS; YOUNG ADULT;

EID: 80052720482     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2010.11.004     Document Type: Article

References (59)

1. Siri P.W., Krauss R.M. Influence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr Atheroscler Rep 2005, 7:455-459.
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002, 106:3143-3421.
3. Arslanian S., Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is " syndrome X" present?. J Clin Endocrinol Metab 1996, 81:1058-1062.
4. Young-Hyman D., Schlundt D.G., Herman L., De Luca F., Counts D. Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care 2001, 24:1359-1364.
5. Azizi F., Salehi P., Etemadi A., Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003, 61:29-37.
6. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
7. Vessby B., Uusitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia 2001, 44:312-319.
8. Vessby B., Gustafsson I.B., Tengblad S., Boberg M., Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 2002, 967:183-195.
9. Riccardi G., Giacco R., Rivellese A.A. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004, 23:447-456.
10. Wang L., Folsom A.R., Eckfeldt J.H. Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Nutr Metab Cardiovasc Dis 2003, 13:256-266.
11. Wang L., Folsom A.R., Zheng Z.J., Pankow J.S., Eckfeldt J.H. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr 2003, 78:91-98.
12. Warensjo E., Riserus U., Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005, 48:1999-2005.
13. Klein-Platat C., Drai J., Oujaa M., Schlienger J.L., Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005, 82:1178-1184.
14. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003, 14:15-19.
15. Azizi F., Rahmani M., Madjid M., Allahverdian S., Ghanbili J., Ghanbarian A., et al. Serum lipid levels in an Iranian population of children and adolescents: Tehran Lipid and Glucose Study. Eur J Epidemiol 2001, 17:281-288.
16. Fung T.T., Hu F.B., Pereira M.A., Liu S., Stampfer M.J., Colditz G.A., et al. Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr 2002, 76:535-540.
17. Kimiagar S.M., Ghaffarpour M., Houshiar-rad A., Hormozdyari H., Zellipour L. Food consumption pattern in the Islamic Republic of Iran and its relation to coronary heart disease. East Mediterr Health J 1998, 4:539-547.
18. Esfahani F.H., Asghari G., Mirmiran P., Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol 2010, 20:150-158.
19. Mirmiran P., Esfahani F.H., Mehrabi Y., Hedayati M., Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran Lipid and Glucose Study. Public Health Nutr 2010, 13:654-662.
20. Wang J., Thornton J.C., Bari S., Williamson B., Gallagher D., Heymsfield S.B., et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003, 77:379-384.
21. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
22. Freire R.D., Cardoso M.A., Gimeno S.G., Ferreira S.R. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care 2005, 28:1779-1785.
23. Sundstrom J., Lind L., Vessby B., Andren B., Aro A., Lithell H. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 2001, 103:836-841.
24. Ohrvall M., Berglund L., Salminen I., Lithell H., Aro A., Vessby B. The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up. Atherosclerosis 1996, 127:65-71.
25. Vessby B., Aro A., Skarfors E., Berglund L., Salminen I., Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 1994, 43:1353-1357.
26. Jones B.H., Maher M.A., Banz W.J., Zemel M.B., Whelan J., Smith P.J., et al. Adipose tissue stearoyl-CoA desaturase mRNA is increased by obesity and decreased by polyunsaturated fatty acids. Am J Physiol Endocrinol Metab 1996, 271(1 pt 1):E44-E49.
27. Dobrzyn A., Ntambi J.M. The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med 2004, 14:77-81.
28. Ghassemi H., Harrison G., Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr 2002, 5:149-155.
29. Artaud-Wild S.M., Connor S.L., Sexton G., Connor W.E. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 1993, 88:2771-2779.
30. Ravnskov U. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol 1998, 51:443-460.
31. Ravnskov U. A hypothesis out-of-date. The diet-heart idea. J Clin Epidemiol 2002, 55:1057-1063.
32. Ravnskov U., Allen C., Atrens D., Enig M.G., Groves B., Kauffman J.M., et al. Studies of dietary fat and heart disease. Science 2002, 295:1464-1466.
33. Taubes G. Nutrition. The soft science of dietary fat. Science 2001, 291:2536-2545.
34. Katan M.B., Zock P.L., Mensink R.P. Dietary oils, serum lipoproteins, and coronary heart disease. Am J Clin Nutr 1995, 61(6 suppl):1368S-1373S.
35. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000, 71:412-433.
36. McCully K.S., Wilson R.B. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975, 22:215-227.
37. Taubes G. Cardiovascular disease. Does inflammation cut to the heart of the matter?. Science 2002, 296:242-245.
38. Rothenbacher D., Hoffmeister A., Brenner H., Koenig W. Physical activity, coronary heart disease, and inflammatory response. Arch Intern Med 2003, 163:1200-1205.
39. Wong N.D., Thakral G., Franklin S.S., L'Italien G.J., Jacobs M.J., Whyte J.L., et al. Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J 2003, 145:888-895.
40. Yarnell J., Yu S., Patterson C., Cambien F., Arveiler D., Amouyel P., et al. Family history, longevity, and risk of coronary heart disease: the PRIME study. Int J Epidemiol 2003, 32:71-77.
41. Wolfram R., Oguogho A., Palumbo B., Sinzinger H. Evidence for enhanced oxidative stress in coronary heart disease and chronic heart failure. Adv Exp Med Biol 2003, 525:197-200.
42. Wang X.L., Raveendran M., Wang J. Genetic influence on cigarette-induced cardiovascular disease. Prog Cardiovasc Dis 2003, 45:361-382.
43. Bjorntorp P. " Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990, 10:493-496.
44. Shen B.J., Todaro J.F., Niaura R., McCaffery J.M., Zhang J., Spiro A., et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 2003, 157:701-711.
45. Asztalos B., Lefevre M., Wong L., Foster T.A., Tulley R., Windhauser M., et al. Differential response to low-fat diet between low and normal HDL-cholesterol subjects. J Lipid Res 2000, 41:321-328.
46. Tholstrup T., Vessby B., Sandstrom B. Difference in effect of myristic and stearic acid on plasma HDL cholesterol within 24 h in young men. Eur J Clin Nutr 2003, 57:735-742.
47. Muller H., Lindman A.S., Brantsaeter A.L., Pedersen J.I. The serum LDL/HDL cholesterol ratio is influenced more favorably by exchanging saturated with unsaturated fat than by reducing saturated fat in the diet of women. J Nutr 2003, 133:78-83.
48. Fessler M.B., Rudel L.L., Brown J.M. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol 2009, 20:379-385.
49. van Dijk S.J., Feskens E.J., Bos M.B., Hoelen D.W., Heijligenberg R., Bromhaar M.G., et al. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr 2009, 90:1656-1664.
50. Kopecky J., Rossmeisl M., Flachs P., Kuda O., Brauner P., Jilkova Z., et al. N-3 PUFA: bioavailability and modulation of adipose tissue function. Proc Nutr Soc 2009, 68:361-369.
51. Hassanali Z., Ametaj B.N., Field C.J., Proctor S.D., Vine D.F. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR: LA-cp rat. Diabetes Obes Metab 2010, 12:139-147.
52. van Hees A.M., Saris W.H., Hul G.B., Schaper N.C., Timmerman B.E., Lovegrove J.A., et al. Effects of dietary fat modification on skeletal muscle fatty acid handling in the metabolic syndrome. Int J Obes (Lond) 2010, 34:859-870.
53. Cabello-Saavedra E., Bes-Rastrollo M., Martinez J.A., Diez-Espino J., Buil-Cosiales P., Serrano-Martinez M., et al. Macronutrient intake and metabolic syndrome in subjects at high cardiovascular risk. Ann Nutr Metab 2010, 56:152-159.
54. Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003, 44:479-486.
55. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6 suppl):1505S-1519S.
56. Nagao K., Yanagita T. Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res 2010, 61:208-212.
57. Yamada M., Sasaki S., Murakami K., Takahashi Y., Uenishi K. Association of trans fatty acid intake with metabolic risk factors among free-living young Japanese women. Asia Pac J Clin Nutr 2009, 18:359-371.
58. Dorfman S.E., Laurent D., Gounarides J.S., Li X., Mullarkey T.L., Rocheford E.C., et al. Metabolic implications of dietary trans-fatty acids. Obesity (Silver Spring) 2009, 17:1200-1207.
59. Micha R., Mozaffarian D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009, 5:335-344.